Skip to main content

Table 4 CMR findings divided by LGE status

From: T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides

 

LGE negative (n = 21)

LGE positive (n = 16)

p

LV-EF (%)

69 ± 7

59 ± 12

0.01

LV-EDV (ml)

117 ± 40

128 ± 44

0.37

LV-ESV (ml)

38 ± 21

56 ± 38

0.06

LV-SV

79 ± 22

72 ± 11

0.43

LV-EDD

47 ± 6

49 ± 4

0.09

LA (cm2)

21 ± 5

20 ± 4

0.54

IVS (mm)

10 ± 2

11 ± 2

0.56

PA (mm)

25 ± 4

25 ± 2

0.75

LV mass (g)

90 ± 25

90 ± 24

0.93

LGE per patient

-

16 (100%)

 

epicardial

-

6 (37%)

 

intramural

-

6 (37%)

 

transmural

-

-

 

subendocardial

-

4 (25%)

 

% LV mass

-

6.8 ± 5

 

Native T1 (ms)

1002 (970–1025)

982 (957–998)

0.10

Post-contrast T1 (ms)

501 (478–542)

477 (429–497)

0.04

ECV (%)

27 (25–28)

28 (26–32)

0.13

T2 (ms)

51 (50–55)

54 (52–56)

0.14

  1. All values are n or mean ± SD or interquartile ranges. CMR cardiac magnetic resonance, LV left-ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume